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INTRODUCTION:  Pseudoangiomatous  stromal  hyperplasia  (PASH)  is  a benign  tumor  of the breast  that  can
achieve large,  or  even  giant,  dimensions.  Resection  of  giant tumors  can  pose  cosmetic  challenges.
CASE  PRESENTATION:  We  report  the  prospective  cosmetic  outcome  of  a 31-year  old  female  with a  21-
cm  PASH  tumor  of the right  breast  using  simple  excision  through  an  inframammary  approach.  The
patient  was  followed  for  6  months  before  ﬁnal  cosmesis  was  established.  Breast  cosmesis  was  consideredeywords:
reast neoplasm
nilateral macromastia
tromal hyperplasia
iant tumor
very  good  by  both  patient  and  physician.  Mild  external  rotation  of  the  nipple  and  mild  contour  changes
involving  the  lateral  aspect  of  the  breast  persisted  at 6 months.
DISCUSSION:  Avoidance  of  more  complex  alternatives  such  as  reduction  mammoplasty  and/or  mastopexy
was  achieved  by  allowing  the skin envelope  to undergo  natural  involution  over  a  period  of  six  months.
CONCLUSION:  Inframammary  simple  excision  of a giant  PASH  tumor  is appropriate  in select  patients.
© 2015  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Pseudoangiomatous stromal hyperplasia (PASH) is a benign
umor comprised of proliferating myoﬁbroblasts, the etiology of
hich appears to have a hormonal inﬂuence. PASH can either
resent as microscopic foci or discrete tumors. These tumors
ay  grow rapidly to impressive dimensions, and achieve discrete
alpability, warranting a designation of tumorous-type PASH, par-
icularly in young women.
Pseudoangiomatous stromal hyperplasia was ﬁrst described by
uitch and colleagues in 1986 as a proliferation of benign myoﬁ-
roblasts that appeared to line pseudovascular spaces [1]. PASH
an present as either microscopic foci or tumorous PASH [2]. Giant
umorous PASH is rare, but well described. The largest reported
umor measurement is 23 cm [3]. Surgical management includes
imple excision, excision with various methods of compensation
or volume loss, and mastectomy with reconstruction. The cosmetic
anagement of giant breast tumor resections of other histologic
ypes has been documented in the literature, but this is the ﬁrst
etailed report of a giant PASH excision that emphasizes cosmetic
utcome.∗ Corresponding author at: University of New Mexico, 1201 Camino de Salud NE,
SC07-4025, Albuquerque, NM,  87131-0001, Fax: +1 505.925.0454.
E-mail address: sgﬁne@salud.unm.edu (S.G. Fine).
ttp://dx.doi.org/10.1016/j.ijscr.2015.08.006
210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Assoc
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Case presentation
This 31-year-old nulliparous Caucasian female presented with a
rapidly enlarging right breast mass spanning 12 months duration.
On physical exam, her right breast was markedly larger than the
left, with a palpable mass occupying the entire lateral aspect of the
breast and measuring 22 cm in greatest diameter and demonstrat-
ing well-circumscribed borders (Fig. 1)
The skin overlying the bulk of the mass was  thinned but
intact, without prominent vascular stigmata. Imaging revealed
a high-density oval lesion with well-circumscribed borders by
mammogram and ultrasound. A percutaneous biopsy (14G Bard
Monopty, Tempe, AZ) revealed non-speciﬁc dense collagenous
tissue. Pre-operative differential diagnosis included giant ﬁbroade-
noma versus PASH versus benign phyllodes tumor. Surgical
excision yielded a ﬁnal diagnosis of PASH.
Pathologic evaluation of the 21 cm × 16 cm × 7 cm gross spec-
imen included a recorded weight of 1,258 g. On sectioning, the
tissue had a relatively homogeneous, lobulated character, and
appeared grossly circumscribed. Histologically, the predominant
pattern that emerged on low magniﬁcation was  one of stromal
expansion with non-proliferative terminal duct lobular units. On
200 × magniﬁcation, clefting of the collagenous tissue revealed
empty spaces lined by banal oval-to-spindle shaped cells. The non-
vascular nature of the slit-like spaces contrasted with red blood
cell-ﬁlled rounded proﬁles of occasional venules within the stroma.
This benign lesion is widely regarded as having a myoﬁbroblastic
origin that lacks atypia or necrosis [4] (Fig 2).
iates Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Intra-operative appearance, right breast giant PASH.
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eig. 2. Microscopic section showing the cleft-like spaces and normal appearing
erminal duct units(H&E 200X).
Surgical management consisted of excision through an infra-
ammary incision (IMI) with allowance for minimal margins. The
ajority of the dissection was performed in the posterior plane
djacent to the pectoralis major, sparing as much of the medially
ompressed tissue as possible. Signiﬁcant lateral deformity was
resent at the conclusion of the operation. The Jackson-Pratt drain
as removed after 4 days.
During the second follow up exam, a palpable seroma was noted
n the previous tumor location. It was left intact, occupying an esti-
ated volume of 300 cc. The seroma was completely reabsorbed by
eek eight. At the 2-month interval, the right breast was remark-
bly similar in contour and size to the left breast and demonstrated
ild ﬂattening of the lateral contour with slight skin wrinkling still
isible. At the 6 -month interval, mild ﬂattening was again noted,
ut the patient reported satisfaction with the result and declined
lastic surgical consultation (Fig 3).
. Discussion
Giant benign tumors of the female breast are deﬁned as tumors
xceeding 5 cm or weighing >500 g [5]. Reports of giant tumors
ost frequently describe large juvenile ﬁbroadenomas or phyllodes
umors in a population that is usually under 20 years of age. Various
urgical management options have been described in the literature.
oncerns about the developing breast bud dictate conservative
xcisional management in the juvenile population, usually through
n inframammary approach [6]. In this series of four patients, with
n age range of 11–15 years, and lesion size of 5.9 cm to 17 cm, an
xcellent cosmetic outcome with excision and subsequent natu-Fig. 3. Six month appearance.
ral remodeling of breast tissue over time is described. Park et al.,
advocated excision with reduction of the skin envelope for giant
breast tumors showing gross distortion [7]. A group of nine young
women, average age 18.5 years, was  treated with excision and
mastopexy through an inverted T-incision with satisfactory results.
Prominent scarring, although infrequent, was  the major adverse
result of this technique. Reduction alternatives were reserved for
cases of true hypertrophy. Ugburo and associates reported treat-
ment results from 22 patients with giant ﬁbroadenomas, 73% of
whom were under age eighteen [8]. Fifteen patients were treated
with simple excision through an inframammary approach (IMI) as
described by Biggers, including those with signiﬁcant ptosis (grade
2 or higher), skin stigmata that included prominent striae, gross
venous dilation, ulceration, or severe asymmetry. Seven patients
were treated with reduction mammoplasty (RM). Excellent cos-
metic outcome with IMI  correlated with absence of skin stigmata or
nipple deviation, and no more then grade two  ptosis. RM produced
better results if the above factors were present, with less redun-
dancy of skin and improved correction of ptosis. Of note, severe
asymmetry in this cohort of patients was due to tumors with an
upper weight of 3300 g and caused signiﬁcantly more distortion
than present in the case described here.
Finally, there is a single report of utilization of a tissue expander
to control the rate of skin contraction after excision of a giant benign
breast tumor. Two patients, age 17 and 19 years, with tumors
that measured 10–11 cm in diameter, underwent serial aspirations
diminishing the tissue expander volume over 6–11 months. Once
the skin envelope had contracted sufﬁciently, the expanders were
removed [9]. Mastectomy for giant PASH, while reported, is not
recommended unless unusual clinical circumstances are present
[10].
4. Conclusion
Existing literature addressing surgical management of giant
tumors of the female breast consists of reports of ﬁbroadenomas
and phyllodes tumors, generally in a juvenile population. Extrap-
olation of this data is reasonable for giant PASH tumors. This
31-year-old patient had grade 2 ptosis, minimal nipple deviation,
and no skin stigmata, all of which predicted good cosmetic out-
come with simple excision of a giant PASH tumor and allowance
for natural shrinkage of the skin envelope over a six month period.
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